Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3

作者：

He, Rong ^{[1
]}

Chiou, Jonathan ^{[2
]}

Chiou, Allison ^{[3
]}

Chen, Dong ^{[1
]}

Chen, Constance P. ^{[4
]}

Spethman, Caroline ^{[5
]}

Bessonen, Kurt R. ^{[1
]}

Oliveira, Jennifer L. ^{[1
]}

Nguyen, Phuong L. ^{[1
]}

Reichard, Kaaren K. ^{[1
]}

Hoyer, James D. ^{[1
]}

Althoff, Simon D. ^{[1
]}

Roh, Dana J. ^{[1
]}

Miller, Mechelle A. ^{[1
]}

Yuan, Ji ^{[1
]}

Olteanu, Horatiu ^{[1
]}

Begna, Kebede ^{[6
]}

Tefferi, Ayalew ^{[6
]}

Alkhateeb, Hassan ^{[6
]}

Patnaik, Mrinal M. ^{[6
]}

Litzow, Mark R. ^{[6
]}

Al-Kali, Aref ^{[6
]}

Viswanatha, David S. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA

[2] Dartmouth Coll, Hanover, NH USA

[3] Wellesley Coll, Wellesley, MA USA

[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA

[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA

[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;

D O I：

10.1038/s41408-022-00612-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[1] Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment
Acha, Pamela
Mallo, Mar
Sole, Francesc
CANCERS, 2022, 14 (22)
[2] Prognostic Markers of Myelodysplastic Syndromes
Veryaskina, Yuliya Andreevna
Titov, Sergei Evgenievich
Kovynev, Igor Borisovich
Pospelova, Tatiana Ivanovna
Zhimulev, Igor Fyodorovich
MEDICINA-LITHUANIA, 2020, 56 (08): : 1 - 16
[3] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
Duong, Vu H.
Padron, Eric
Al Ali, Najla H.
Lancet, Jeffrey E.
Hall, Jeff
Kwok, Brian
Zhang, Ling
Epling-Burnette, Pearlie K.
List, Alan F.
Komrokji, Rami S.
ANNALS OF HEMATOLOGY, 2018, 97 (02) : 247 - 254
[4] Molecular Testing in Patients with Suspected Myelodysplastic Syndromes
Moyo, Tamara K.
Savona, Michael R.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 441 - 448
[5] Evaluation of the Selected Parameters of Bone Marrow Cell Subpopulations by Flow Cytometry and Analysis of Their Diagnostic and Prognostic Value in Patients with Myelodysplastic Syndromes
Majcherek, Maciej
Kiernicka-Parulska, Jolanta
Mierzwa, Anna
Bara, Marta
Komarnicki, Mieczyslaw
Lewandowski, Krzysztof
Czyz, Anna
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S338 - S338
[6] Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
Shahjahani, Mohammad
Hadad, Elham Homaei
Azizidoost, Shirin
Nezhad, Kowsar Chenani
Shahrabi, Saeid
ONCOLOGY REVIEWS, 2019, 13 (01) : 30 - 36
[7] ProGraME: A novel flow cytometry algorithm for the diagnosis of low-risk myelodysplastic syndromes in patients with cytopenia
Therkelsen, Jesper
Traeden, Dicte Wilhjelm
Schjodt, Ida
Andersen, Mette Klarskov
Sjo, Lene Dissing
Hansen, Jakob Werner
Gronbaek, Kirsten
Dimopoulos, Konstantinos
EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) : 851 - 862
[8] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes
Kewan, Tariq
Bahaj, Waled
Durmaz, Arda
Aly, Mai
Ogbue, Olisaemeka D.
Carraway, Hetty E.
Sekeres, Mikkael A.
Visconte, Valeria
Gurnari, Carmelo
Maciejewski, Jaroslaw P.
BLOOD, 2023, 141 (14) : 1768 - 1772
[9] Prognostic evaluation of the microvascular network in myelodysplastic syndromes
P Korkolopoulou
E Apostolidou
PM Pavlopoulos
N Kavantzas
N Vyniou
I Thymara
E Terpos
E Patsouris
X Yataganas
P Davaris
Leukemia, 2001, 15 : 1369 - 1376
[10] Prognostic evaluation of the microvascular network in myelodysplastic syndromes
Korkolopoulou, P
Apostolidou, E
Pavlopoulos, PM
Kavantzas, N
Vyniou, N
Thymara, I
Terpos, E
Patsouris, E
Yataganas, X
Davaris, P
LEUKEMIA, 2001, 15 (09) : 1369 - 1376

← 1 2 3 4 5 →